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ABSTRACT 
INTRODUCTION: Long-acting reversible contraceptives (LARCs) can significantly reduce 
incidence of teen pregnancy and unintended pregnancy and indirectly reducing the rate of 
abortion, preterm birth, and low birthweight.  A cohort study and two statewide interventions in 
the United States have demonstrated the impact LARCs have, yet uptake in the United States 
remains relatively slow, particularly among 15 to 24-year-olds, who have the highest rates of 
unintended pregnancy.  Access to effective forms of birth control is an issue of public health 
significance as it is linked to negative maternal and neonatal health outcomes.  One of the causes 
of low LARC use is that fewer family planning clinics provide them.  The purpose of this work 
is to examine the reasons why disparities in LARC access persist as well as the ways in which 
Pennsylvania, and in particular rural communities, could benefit from a statewide initiative to 
increase LARC access. 
METHODOLOGY: Statewide data from the 2017 Family Planning Annual Report was 
obtained from each of the four organizations responsible for distributing Title X funding in 
Pennsylvania.  Each organization provided reports on the insurance status and primary birth 
control method of female patients at Title X clinics in their respective region of the state. 
RESULTS: Title X clinics in Pennsylvania primarily serve uninsured and publicly insured 
individuals as compared to statewide insurance proportions.  Fewer Title X patients in 
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Pennsylvania use LARCs than patients nationwide, and high disparities exist between rural and 
urban Pennsylvania counties.  The organizations that oversaw Pittsburgh’s two largest cities, 
Philadelphia and Pittsburgh, had higher rates of LARC use than the organizations that did not 
include a large urban area.   
CONCLUSION: Findings suggest a disparity in LARC access between urban and rural 
communities, and a clinic-by-clinic assessment of birth control methods offered is a 
recommended next step.  As low-income women are at an increased risk of unintended 
pregnancy, Title X clinics need to be capable of providing patients with the most effective 
methods of birth control. 
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1.0  INTRODUCTION 
Approximately 45% of pregnancies in the United States (U.S.) are unintended as of 2011 (Finer 
& Zolna, 2016).  While this is a decrease from 51% in 2008, research in 2012 shows North 
America, defined as the U.S. and Canada, lags behind the western and northern regions of 
Europe, which report rates of 34% and 38%, respectively (Sedgh, Singh, & Hussain, 2014). 
Some research indicates that jointly, unintended, teen, and “rapid repeat” pregnancies have been 
tied to multiple negative health outcomes, including increased rates of maternal depression, low 
birth weight, low breastfeeding rates, and intimate partner violence (Parks & Peipert, 2016). 
In the past ten years numerous programs have advocated the use of long-acting reversible 
contraceptives (LARCs).  The Contraceptive CHOICE Project, a St. Louis-based study, 
encouraged women to use LARCs by removing barriers such as cost, access, and patient 
knowledge.  The study recruited women at increased risk for unintended pregnancy, including 
women under 25, with low socioeconomic status, or from a minority background.  Women using 
non-LARC methods were over 22 times more likely to experience an unintended pregnancy 
compared to LARC users (McNicholas 2014).  
The Colorado Family Planning Initiative (CFPI) was established in 2009 by the Colorado 
Department of Public Health and Environment (CDPHE) (Dube 2015). The goal was to provide 
training, outreach, and assistance to family planning clinics that received Title X funding; the 
initiative also provided funds to clinics to offer free long-acting reversible contraceptives 
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(LARCs), vasectomies, and tubal ligations.  Over 100 public health centers received funds 
through CFPI (Dube 2017).   
Every year the Department of Health and Human Services’ Office of Population Affairs 
publishes a Family Planning Annual Report (FPAR) that summarizes the services and 
capabilities of Title X grantees on a national level.  Four Title X grantees in Pennsylvania are 
responsible for tracking and submitting data: AccessMatters, Adagio Health, Maternal and 
Family Health Services, Inc., and Family Health Council of Central Pennsylvania, Inc.  The data 
submitted in these reports include family planning user demographics, income and insurance 
status, and contraceptive method use.  Using these data, which have previously only been 
presented on a national or multi-state scale, a statewide snapshot of Title X family planning 
clients will be constructed to illustrate the number of Pennsylvania using LARCs as compared to 
other methods.   
This thesis highlights statewide social and economic benefits to Pennsylvania launching 
its own version of the CFPI.  This will provide a basis for policy makers at the state level to 
argue that funds be allocated to such a program. 
This paper will begin with a background of unintended pregnancies, including literature 
regarding disparities between racial, economic, and geographic groups in the United States and 
Pennsylvania; the impact of unintended pregnancies on maternal and child health; the state and 
federal costs incurred by unintended pregnancies; policy and access issues around contraception 
and abortion; and background on long-acting reversible contraceptives.  Additionally, three 
interventions that demonstrated the impact of increasing access to long-acting reversible 
contraceptives will be reviewed: the Contraceptive CHOICE Project, the Colorado Family 
Planning Initiative, and Delaware Contraceptive Access Now.  Next, data collection methods 
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will be described, followed by a summary of the data.  Then, findings will be discussed and 
compared to national level data and to outcomes in the aforementioned interventions.  This 
discussion will also include suggestions of community partners that could aid in the proposed 
intervention as well as the potential impact of such an intervention.  Finally, the paper will end 
with next steps that should be taken to pursue support for a statewide intervention.  
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2.0  BACKGROUND 
Unintended pregnancies (UIPs) are defined as pregnancies that are either unwanted, which make 
up 27% of all pregnancies, or mistimed, which make up 18% of all pregnancies (Guttmacher 
Institute, 2016).  A pregnancy is defined as mistimed if the woman has become pregnant earlier 
than she intended while a pregnancy is unwanted if the woman had no intention of becoming 
pregnant (D'Angelo, Gilbert, Rochat, Santelli, & Herold, 2004).  Unintended and teen pregnancy 
rates vary by demographics, including race and geographic classification, and can increase the 
risk of negative maternal and infant health outcomes.  Recent interventions have shown that 
increasing access to highly effective forms of contraception can reduce unintended and mistimed 
pregnancies and decrease the need for state and federal funded services such as Medicaid. 
2.1 DEMOGRAPHICS OF UNINTENDED PREGNANCIES 
Women ages 20 to 24-years-old have the highest rate of unintended pregnancies in the US, at 81 
UIPs per 1,000 women.  In 2011, this equated to 878,000 unintended pregnancies, 59% of all 
pregnancies for that age group.  The next highest rate was among 18 to 19-year-olds at 71 per 
1,000.  Seventy-six percent of all pregnancies in this age group, 305,000 in 2011, were 
unintended.  
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By race, black non-Hispanic women are more likely than women of other races to have 
an unintended pregnancy: 79 for every 1,000, compared to 33 for non-Hispanic white women.  
Out of all pregnancies among black non-Hispanic women, 69% were unintended, compared to 
only 38% for white non-Hispanic women.  Hispanic women experience UIPs at a rate of 58 per 
1,000, and 50% of all pregnancies are classified as unintended.  Differences also exist by 
education level: women who have not completed high school or received a GED have a rate of 
73 UIPs per of 1,000, making up 45% of all pregnancies in that group.  High school graduates 
experience a lower rate of unintended pregnancies, 59, but 54% of pregnancies are unintended.  
As education increases, the rate and percentage of UIPs decrease, with 46% of pregnancies being 
unintended among those with some college and 27% among college graduates.  
Low-income women disproportionately experience unintended pregnancy.  In 2011, there 
were 112 UIPs for every 1,000 women with incomes below 100% of the federal poverty level 
(FPL).  At 100-199% of the FPL 58 UIPs per 1,000 women occurred.  In contrast, women at or 
above 200% of the federal poverty level had a rate of 20 UIPs per 1,000.   
2.2 IMPACT OF UNINTENDED PREGNANCIES 
2.2.1 Maternal and Child Health 
Per the Guttmacher Institute, U.S. women spend an average of three decades trying to avoid an 
unintended pregnancy (Guttmacher Institute, 2016). Women shoulder the financial, physical, and 
emotional burden of the most effective types of contraception as well as the consequences of 
unplanned pregnancies, such as poverty, stigma, and the struggle to obtain an abortion.   
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Women who experience an UIP can be at an increased risk for negative social, economic 
and health outcomes.  Adolescents who become pregnant are less likely to finish high school or 
receive a GED, relative to similar adolescents who do not become pregnant, leading to limited 
economic opportunities (Perper, 2010).  Additionally, women without a high school diploma or 
GED have been found to have worse health outcomes than women who completed high school, 
including decreased life expectancy (Kaplan, Fang, & Kirby, 2017).  Adolescents are at an 
increased risk of rapid repeat pregnancies, or pregnancies occurring within two years of a 
previous pregnancy, and these pregnancies are more likely to result in stillbirth or premature 
birth (Baldwin & Edelman, 2013).  UIPs are linked to higher rates of maternal depression, low 
birthweight, lower breastfeeding rates, and intimate partner violence.  Long-term outcomes for 
children resulting from UIPs include poorer mental, physical, and behavioral health (Parks & 
Peipert, 2016). 
2.2.2 State and federal costs 
In 2010, unintended pregnancies cost the United States $21 billion in public expenditures.  In 
Pennsylvania, $726.8 million were spent on UIPs, with $248.2 million of that paid by the state.  
This covered the 31,000 unplanned births that were publicly funded, 53.5% of all births in 
Pennsylvania that year.  Per woman, UIPs cost $298 in Pennsylvania, compared to $201 
nationally.  Without current funding for family planning programs, $434.4 million more state and 
federal funds would have been spent on childbirth costs, Medicaid, WIC, and CHIP because of 
two million additional unintended pregnancies (Guttmacher Institute, 2017). 
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2.3 CONTRACEPTION AND ABORTION 
2.3.1 Contraception in the United States 
Sixty-eight percent of women at risk for pregnancy (i.e. cisgender, sexually-active 
premenopausal women) consistently use contraception and account for just 5% of UIPs.  
Eighteen percent of women at risk of pregnancy use birth control either inconsistently or 
incorrectly and account for 41% of UIPs.  Fourteen percent of women at risk use no birth control 
or have gaps of one month or more and account for 54% of UIPs (almost 1.7 million pregnancies 
in 2008) (Guttmacher Institute, 2016).  Multi-state surveys showed 45.2% of girls between 15 
and 19 who gave birth had at some point used “moderate or very effective” birth control, 
indicating that adherence is an issue for adolescents (Yoost, 2014).   
Oral contraceptives (“the pill”), which require daily compliance, are the most commonly 
used method.  As of 2014, 25.3% of contraceptive users between the ages of 15 and 44 use the 
pill (Guttmacher Institute, 2018), and 20.7% of sexually active adolescents use the pill.  The pill 
has a 7% failure rate, but among adolescents, it has a failure rate of 10% to 15% (Davtyan, 
2000).  The patch and shot are also commonly used by adolescents.  One Centers for Disease 
Control and Prevention (CDC) report estimated that in 2011-2013, 2% of teenagers had 
previously used a transdermal contraceptive patch, 15% used Depo-Provera (the shot), 3% used 
an intrauterine device (IUD), and 2% had used a hormonal implant.  The patch and shot are both 
more popular among adolescents than other age groups; in 2014 0.1% of women aged 15 to 44 
used the patch and 2.4% used the shot.   
Condoms are the most accessible form of birth control; however, they are categorized as 
“less effective” and have a typical use failure rate of 18%.  The 2017 Youth Risk Behavior 
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Survey found that among sexually active high school students, only 53.8% reported using a 
condom during their last sexual encounter (CDC, 2017). 
2.3.2 Abortion in the United States 
Forty-two percent of unintended pregnancies are aborted, and in 2014,  75% of abortion patients 
had incomes at or below 199% of the FPL.  However, due to the Hyde Amendment,  abortion is 
disproportionately inaccessible to low-income women(Guttmacher Institute, 2016).  Under the 
amendment, abortion is not covered by publicly funded insurance in a majority of states except 
in cases of rape, incest, or to save the life of the mother (Boonstra, 2016), and can cost up to 
$950 out-of-pocket (Planned Parenthood, 2014).  This does not include costs due to travel, 
childcare, or lost income.   
2.4 UNINTENDED PREGNANCIES IN PENNSYLVANIA 
Per the Pregnancy Risk Assessment Monitoring Survey (PRAMS) Pennsylvania report, in 2016 
34.3% of pregnancies were “mistimed or unwanted” while 19.5% of respondents were “unsure 
about pregnancy” (CDC, 2018).  However, the PRAMS surveys only women who experience 
live births, excluding women who experience miscarriage, stillbirth, and abortion.  Per the 
Guttmacher Institute, in 2010, 53% of all Pennsylvania pregnancies, regardless of outcome, were 
classified as unintended.  Of those, 66% were mistimed while 34% were unwanted.  Thirty-five 
percent of Pennsylvania UIPs ended in abortion, 52% ended in birth, and 13% were miscarried 
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(Kost, 2015).  As of 2014, 1,523,010 Pennsylvania women and girls needed family planning 
services, and 745,550 of those were in need of publicly-funded services (Frost, 2016). 
 In 2013, the adolescent pregnancy rate (APR) for Pennsylvania was 35 per 1,000 women 
aged 15-19; the national rate was 43 per 1,000.  Seventy-five percent of adolescent pregnancies 
are unintended (Guttmacher Institute, 2017).  Although state and age-specific pregnancy rates are 
unavailable, in 2015, the adolescent birth rate (ABR) for 15-19-year-old Pennsylvanian women 
was 17.6 per 1,000 (Pennsylvania Department of Health, 2018) while the rate for the United 
States was 22.3 (National Vital Statistics System, 2017).  Overall, Pennsylvania experiences 
significantly lower rates of adolescent birth than the rest of the country; however, county level 
data show significant differences within the state (Table 1).  The below table presents the crude 
age-specific birth rate for girls aged 15 to 19 by county.   
Table 1. Pennsylvania Births: Crude/Age-Specific Birth Rates per 1,000 females 15-19 years old 
County/State Count Population 
Crude/Age-Specific Birth 
Rate 
Lower 
Bound 
Upper 
Bound 
Pennsylvania 7,172 407,629 17.6 17.2 18 
Venango 49 1,446 33.9 24.4 43.4 
Bradford 59 1,758 33.6 25 42.1 
Fayette 122 3,642 33.5 27.6 39.4 
Elk 28 867 32.3 20.3 44.3 
Philadelphia 1,598 49,909 32 30.4 33.6 
Fulton 13 437 29.7 13.6 45.9 
Jefferson 37 1,296 28.5 19.4 37.7 
Mifflin 38 1,344 28.3 19.3 37.3 
Northumberland 63 2,276 27.7 20.8 34.5 
Potter 13 475 27.4 12.5 42.2 
Franklin 120 4,712 25.5 20.9 30 
Somerset 49 1,940 25.3 18.2 32.3 
Luzerne 240 9,572 25.1 21.9 28.2 
Lawrence 66 2,657 24.8 18.8 30.8 
Greene 26 1,124 23.1 14.2 32 
Blair 84 3,651 23 18.1 27.9 
Bedford 31 1,372 22.6 14.6 30.5 
Clearfield 47 2,083 22.6 16.1 29 
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Table 1 Continued 
Lehigh 266 11,966 22.2 19.6 24.9 
McKean 30 1,354 22.2 14.2 30.1 
Lebanon 93 4,213 22.1 17.6 26.6 
Dauphin 176 8,023 21.9 18.7 25.2 
Lycoming 76 3,470 21.9 17 26.8 
Armstrong 38 1,743 21.8 14.9 28.7 
Cambria 92 4,216 21.8 17.4 26.3 
Lackawanna 147 6,749 21.8 18.3 25.3 
Erie 210 9,702 21.6 18.7 24.6 
Montour 10 467 21.4 8.1 34.7 
Tioga 32 1,494 21.4 14 28.8 
Berks 309 14,554 21.2 18.9 23.6 
Carbon 36 1,698 21.2 14.3 28.1 
Warren 23 1,097 21 12.4 29.5 
York 277 13,554 20.4 18 22.8 
Perry 25 1,292 19.3 11.8 26.9 
Crawford 57 2,967 19.2 14.2 24.2 
Adams 65 3,461 18.8 14.2 23.3 
Schuylkill 69 3,700 18.6 14.2 23 
Beaver 83 4,491 18.5 14.5 22.5 
Huntingdon 27 1,457 18.5 11.5 25.5 
Mercer 69 3,738 18.5 14.1 22.8 
Clinton 29 1,606 18.1 11.5 24.6 
Lancaster 292 17,955 16.3 14.4 18.1 
Susquehanna 18 1,178 15.3 8.2 22.3 
Juniata 11 756 14.6 6 23.1 
Columbia 43 3,030 14.2 9.9 18.4 
Westmoreland 136 9,920 13.7 11.4 16 
Washington 85 6,289 13.5 10.6 16.4 
Snyder 20 1,570 12.7 7.2 18.3 
Allegheny 455 36,121 12.6 11.4 13.8 
Northampton 126 9,961 12.6 10.4 14.9 
Pike 21 1,761 11.9 6.8 17 
Monroe 76 6,528 11.6 9 14.3 
Delaware 226 19,688 11.5 10 13 
Butler 72 6,455 11.2 8.6 13.7 
Union 18 1,751 10.3 5.5 15 
Cumberland 85 8,449 10.1 7.9 12.2 
Indiana 37 3,829 9.7 6.5 12.8 
Wayne 11 1,390 7.9 3.2 12.6 
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While Pennsylvania has the 15th lowest ABR among U.S. states, three counties have 
ABR rates on par with Arkansas, which has the highest ABR, 34.6 births per 1,000 teens 
(Martin, 2018).   
2.5 URBAN-RURAL DISPARITIES 
From 2007 to 2015, teen births decreased 50% in urban counties nationally, from 38.1 births per 
1,000 to 18.9 (Hamilton, Rossen, & Branum, 2016).  In medium and small urban counties teen 
births dropped 44% (43.1 to 24.3).  Meanwhile in rural counties the teen birth rate dropped 37% 
from 49.1 births per 1,000 to 30.9 births per 1,000, higher than the national average (Romero et 
al., 2016).   
Forty-eight out of 67 Pennsylvania counties are classified as rural by the Center for Rural 
Pennsylvania.  By state, Pennsylvania (along with Alaska, Maryland, Montana, and North 
Dakota) reported the smallest decreases in rural county ABR, less than 30%.  From 2007 to 
2015, teen birth rates in urban Pennsylvania decreased 44.7% while the rate in rural areas 
decreased by only 24.8%.  Of the 10 Pennsylvania counties with the highest ABRs (see Table 1), 
nine are rural.  Among the counties with the lowest ABR, six are rural and four are urban.   
Urban-rural differences exist across racial groups: the ABR for non-Hispanic white teens 
was 10.5 in urban counties, nationwide, and 26.8 in rural counties.  For non-Hispanic black 
teens, the urban ABR was 29.1 while the rural ABR was 39.6, and for Hispanic teens the rate 
was 31.4 in urban areas and 47.0 in rural areas (Hamilton et al., 2016).  Although fewer data are 
available for other racial groups, a 2013 report showed similar differences for Asian/Pacific 
Islander teens (8.7 in urban and 25.6 in rural counties) and Native American teens (17.6 in urban 
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and 65.7 in rural) (Ng & Kaye, 2015).  State level data on the rural-urban difference among 
racial groups could not be found.   
Rural teens are also less likely to be well-educated about birth control.  Per the 
Guttmacher Institute, declines in formal education on contraception have been concentrated in 
rural areas (Lindberg, Maddow-Zimet, & Boonstra, 2016). From 2006 to 2013, formal 
instruction decreased from 71% to 48% for rural girls and 59% to 45% for rural boys.  In a 
qualitative study of rural educators’ attitudes towards in-school sex education, rural educators 
perceived two main barriers as compared to urban educators.  Per respondents, rural schools 
faced more monitoring by churches, school boards, and community members as well as an 
overall increased level of religiosity (Blinn‐Pike, 2008).   
2.6 LONG-ACTING REVERSIBLE CONTRACEPTIVES 
This thesis focuses on the uptake of long-acting reversible contraceptives (LARCs).  LARCs are 
methods of contraceptives that require little or no user action to be effective.  Two types of 
contraceptives are classified as LARCs by the American College of Obstetricians and 
Gynecologists (ACOG): intrauterine devices (IUDs) and hormonal implants.  Once inserted by a 
physician, these methods last for long periods of time and are more than 99% effective.  Unlike 
other contraceptives, their rates of typical use and perfect use are identical because after the 
initial insertion no follow-up action is required.  LARCS were used by 16% of all female 
contraceptive users in 2017 (Fowler, 2018) and by 4.3% of adolescent contraceptive users (Coles 
& Shubkin, 2018).   
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IUDs come in hormonal and nonhormonal forms.  There are four types of hormonal 
IUDs, all of which emit progestin.  Depending on the type of hormonal IUD, it is effective for 
three to seven years.  The nonhormonal IUD, Paragard, is made of copper and lasts for 12 years.  
The implant, which lasts four years, is placed under the skin of the arm.   
Use of LARCs differs by region, and several studies have shown differences based on 
urban-rural classification.  A survey of Title X family planning providers Texas in 2008-2009 
found that urban clinics were more likely to provide LARCs than rural clinics (Vaaler, Kalanges, 
Fonseca, & Castrucci, 2012).  Additionally, 75% of urban providers had “adequate” LARC 
training while only 57% of rural providers did.  A 2016 survey on the attitudes of pediatricians 
towards LARCs found that severe knowledge deficits exist (Berlan, Pritt, & Norris, 2017).  Most 
surveyed pediatricians held unfavorable views on IUDs for adolescents and did not include IUDs  
in birth control counseling.  Concerns about safety persist, stemming largely from the Dalkon 
Shield, an IUD that was banned in 1983 following high rates of infertility, pelvic inflammatory 
disease (PID), and septic maternal death.  IUD usage in the U.S. decreased following 
discontinuation of the Dalkon Shield, and “more than a generation of health care providers were 
instructed that IUDs should only be used by parous women in a monogamous relationship” 
(Berlan et al., 2017, p. 50).  However, recent studies have shown that the risk of PID is no higher 
for IUD users than for the general population (Straub, Reynaud, & Yaron, 2018).  There is an 
increase in risk (6.3 times greater) of PID in the first 20 days following insertion; however, this 
has been found to be due to bacterial contamination during the procedure (Yoost, 2014).  
Dual-method contraception is the use of a moderately or highly effective contraceptive as 
well as a condom to prevent pregnancy and STI transmission.  A concern with LARCs is that 
they do not prevent STI transmission.  In the 2006-2008 National Survey of Family Growth only 
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3.3% of people with LARCs also used condoms compared to 21.7% of pill users, 16% of patch 
users, 16.7% of shot recipients, and 32.6% of ring users.  Another study found that 15 to 19-year-
olds using LARCs or the shot were almost twice as likely as women 20 years and older to use 
condoms (Williams & Fortenberry, 2013). 
2.7 PREVIOUS INTERVENTIONS 
As mentioned above, despite their high effectiveness in preventing pregnancy, LARCs are used 
by only a small percentage of contraceptive users.  Recent interventions have shown the benefits 
of increasing LARC use, both for women and for state and federal social programs. 
2.7.1 Contraceptive CHOICE Project 
The Contraceptive CHOICE Project, launched in 2007, was a prospective cohort study 
conducted by Washington University in St. Louis, Missouri.  Investigators estimated that less 
than 5% of St.  Louis women were using LARC methods.  CHOICE’s purpose was to assess the 
change in LARC use rates if barriers of cost, patient knowledge, and access were removed.  A 
representative cohort of 9,256 women was recruited to participate.  Women were eligible if they 
were 14 to 45 years old, were sexually active with a man or planned to be, wanted to avoid 
pregnancy for at least one year, and were interested in starting a new contraceptive method 
(McNicholas, Madden, Secura, & Peipert, 2014). 
Once enrolled, participants were counseled on different birth control methods using a 
script designed to provide accurate and unbiased information on all reversible contraceptive 
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methods and assist participants in choosing the best device for their needs.  Participation in the 
study lasted two to three years, during which women were provided with their preferred method 
at no cost.  Women were free to change their method as many times as they wanted.  
Demographic and medical histories were collected at baseline, and phone interviews were 
conducted at three and six months after enrollment and thereafter every six months for the 
remainder of the study period. 
A baseline survey of contraceptive knowledge was conducted at the beginning of the 
study, during which it was revealed respondents that generally underestimated the effectiveness 
of LARCs.  Sixty-five percent correctly identified the effectiveness of IUDs while 55% correctly 
identified the effectiveness of implants.  Additionally, 45% of participants overestimated the 
effectiveness of the pill, patch, and ring methods.  Following contraceptive counseling, 75% of 
participants chose a LARC method.  Continuation rates were higher for LARC users than non-
LARC users, with 86% continuation at 12 months and 77% at 24 months, compared to 55% and 
41%, respectively.  Among those who chose the pill, patch, or ring, the failure rate was 9.4% at 
the three-year mark while the failure rate for LARC users was less than 1%.  Participants who 
chose non-LARC methods were over 22 times as likely to experience an unintended pregnancy 
compared to those who used LARCs.  During the study, abortion rates among all participants 
was less than half the regional rate and the national rate.  Among adolescent participants, 
pregnancy, birth, and abortion were all reduced by more than 75% (McNicholas et al., 2014).  
2.7.2 Colorado Family Planning Initiative 
The Colorado Family Planning Initiative (CFPI) was established in 2009 by the Colorado 
Department of Public Health and Environment (CDPHE).  Its goal was to provide training, 
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outreach, and assistance to family planning clinics that received Title X funding; the initiative 
also provided funds to clinics to offer free LARCs, vasectomies, and tubal ligations.  Over 100 
public health centers received funds through CFPI to purchase LARCs.  The CFPI also trained 
health care staff and provided operational support for clinics.  Clinics were able to improve their 
billing practices, increase their hours of operation, hire additional staff, open new sites, and 
develop relationships with local community partners (CDPHE, 2017). 
Between 2009 and 2015 the CFPI provided LARCs to more than 30,000 Colorado 
women (Dube, 2015).  By 2015 the percent of Title X patients using LARCs had increased from 
6.4% to 30.5%.   Statewide, among adolescents the UIP rate decreased by 40%, and among 
women 20 to 24 it decreased by 20%.  Using a decision-analytic model, CDPHE calculated that 
nearly half of the decline among adolescents and 39% of the decline among 20 to 24-year-olds 
was due to the CFPI. 
Adolescent births decreased by 40%, and adolescent abortion declined by 35%.  Repeat 
adolescent births decreased by 57% and repeat births among 20 to 24-year-olds decreased by 
19%.  At the start of the program, 19.8% of Colorado women giving birth did not have a high 
school diploma; by 2014 that was reduced to 12.2%.  The CDPHE monitored the change in high 
risk births over the course of the initiative.  High risk births in this instance are defined as births 
to mothers under 25 who are unmarried and have not completed high school; these factors 
increase the likelihood of poor infant health outcomes, living in poverty, and greater need of 
government assistance.   Over the course of the initiative, high risk births in Colorado dropped 
from 6.4% to 3.4% (CDPHE, 2017).  For rural Colorado counties, the adolescent birth rate 
decreased 50.7% from 2007 to 2015, compared to the national decrease of 37.1%.  For urban 
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counties the adolescent birth rate decreased 53.8% compared to the national average of 47.6% 
(Hamilton et al., 2016). 
CDPHE estimated that the CFPI was directly responsible for an overall reduction of 17% 
in pregnancies, births, miscarriages, and abortions among adolescents and a 7.8% reduction of 
the same outcomes for 20 to 24-year-olds.  Because the time frame coincided with the rollout of 
the Affordable Care Act and a nationwide decrease in fertility rates, the CDPHE compared 
Colorado to control groups comprised of counties in other states with similar characteristics to 
Colorado counties.  Thus adjusted trends were calculated to show the specific impact of the 
CFPI. 
Costs avoided were calculated for Medicaid, Temporary Assistance for Needy Families, 
Supplemental Nutrition Assistance Program, and Special Supplemental Nutrition Program for 
Women and Children.  Between $66 million and $69.6 million in costs were saved from 2010 to 
2014 due to the CFPI.  In comparison, the entire initiative was funded with a $27.3 million grant, 
or a little over $5 million a year. 
 Clinic training during the grant had a significant impact on the sustainability of the 
program.  Title X clinics were encouraged to transition from operating as free clinics to 
businesses capable of generating income.  At the start of the grant period, 20% of clinic revenue, 
totaling $345,000, was from third-party payers like Medicaid and private insurance while 80% of 
revenue collected in Title X clinics was from clients.  In 2014, 75% of revenue, more than $4 
million, was being collected from third-party payers while only 25% was paid by clients.  This 
decreased the amount of funding needed to maintain the CFPI.  When grant funding ended in 
2015, the CDPHE was able to maintain the program on only $2.5 million per year, rather than 
the $5 million that had been required at the beginning of the initiative.  Additionally, the CDPHE 
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established a formal referral system so that clinics that remained unable or unwilling to provide 
LARCs were prepared to refer patients who sought LARCs to the closest clinic that provided 
them (CDPHE, 2017).   
2.7.3 Delaware CAN  
In 2014, Upstream USA (Upstream), a healthcare non-profit, launched Delaware CAN 
(Contraceptive Access Now), a statewide initiative to provide all Delaware women with easy 
access to their preferred method of contraception.  Upstream has partnered with the Delaware 
Division of Public Health and the governor to work with health centers to improve staff 
knowledge, counseling abilities, and confidence so that clinics are able to offer single-visit 
access to all forms of contraceptives.  In its first four years, Upstream has worked with 41 
agencies to improve 165 health care delivery sites (Welti, 2018).   
Though Delaware CAN is ongoing, in 2018 Upstream commissioned Child Trends, a 
nonprofit research center, to analyze the impact of the program to date.  This report looked at 
Title X family planning patients between the ages of 20 and 39, excluding 15 to 19-year-olds due 
to incorrect method categorization.  Additionally, Child Trends excluded from the analysis 
women who were trying to become pregnant, reported they were abstinent, or had their 
contraceptive method listed as “unknown.”  Among 20 to 39-year-olds, LARC use increased 
from 13.7% to 27% from 2014 to 2016.  In comparison, nationally the rate increased from 13.6% 
to 17.6%.  As LARC users increased, there was an accompanying decrease in the number of 
women using the pill, patch or ring; there was also a nearly 2% decrease in the number of 
patients using no method.  Child Trends conducted simulations using a microsimulation tool 
called FamilyScape to estimate the impact Delaware CAN has had on Title X patients thus far.  
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Per the analysis, the unintended pregnancy rate dropped from 106 per 1,000 women to 89.7, a 
decrease of 15.4%.  In the same time frame, the national rate decreased by 1.3%. 
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3.0  METHODS 
The goal of this thesis is to demonstrate that Pennsylvanian women would benefit from a 
statewide LARC-focused intervention and that such an intervention would decrease unintended 
and teen pregnancies and decrease reproductive health disparities between rural and urban 
counties.  To achieve this, aggregate level data were collected from Pennsylvania clinics that 
receive Title X funding.  The Office of Family Planning, part of the Office of Population Affairs, 
collects data on the use of Title X funds annually and publishes the Family Planning Annual 
Report (FPAR).  FPAR presents the collected data at a national level as well as by regions 
designated by the Department of Health and Human Services (HHS).  These ten regions 
encompass multiple states; Pennsylvania is in Region III, which also includes Delaware, 
Maryland, Virginia, Washington, D.C., and West Virginia.  Grantees within each region are 
granted Title X funding and are required to submit annual reports on the use of this funding 
(Office of Population Affairs, 2018a). 
3.1 DATA COLLECTION 
Four organizations in Pennsylvania receive Title X funding (Office of Population Affairs, 2018b) 
and are responsible for dispersing Title X funds to 164 subgrantees (see Appendix A), i.e. 
medical providers of family planning services, as well as collecting data from subgrantees for the 
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FPAR.  The four Title X grantees in Pennsylvania are AccessMatters, Philadelphia, PA; Adagio 
Health, Pittsburgh, PA; Maternal and Family Health Services, Inc. (MFHS), Wilkes-Barre, PA; 
and Family Health Council of Central Pennsylvania, Inc. (FHCCPA), Camp Hill, PA.  Each of 
these grantees is responsible for a discrete section of Pennsylvania (see Figure 1).  Clinics send 
monthly reports compiled from electronic medical records to the organization that provides their 
Title X funding. These reports are compiled to create the annual FPAR report sent to HHS. 
 
Figure 1. Title X Grantees of Pennsylvania 
Stransky 2018 
 
Each of the four organizations was contacted for Title X clinic data.  Responses were 
received from Tamar Klaiman, Director of Research and Evaluation for AccessMatters; Linda 
Snyder, Director of Evaluation and Strategic Analysis for Adagio Health; John Kearney, Vice 
President of Program Services and Business Initiatives for MFHS; and Kacey Schneider, 
Director of Provider Relations for FHCCPA.   
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All four organizations provided aggregate data for two sections of the 2017 FPAR: 
“Table 5: Unduplicated Users by Principal Health Insurance Coverage Status” and “Table 7: 
Unduplicated Females by Primary Method and Age Group.” Table 5 includes data for all family 
planning users, regardless of gender, and Table 7 only includes information from patients who 
identify as female.  Women who use more than one type of contraceptive (e.g. an implant and 
condoms or the patch and spermicide) are only counted for the most effective method they use to 
avoid duplication. The variables measured for insurance were the principal coverage status: 
private insurance, public insurance, uninsured, or coverage unknown.  For primary method of 
family planning, counts were given by method and age group. LARC use measured by 
combining the counts of individuals using either a hormonal implant or an IUD, and percentages 
were calculated for each age group to show how primary method differed by age group. 
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4.0  RESULTS 
Pennsylvania has 164 Title X-funded clinics (Figure 2) which, in 2017, provided family 
planning services to 175,036 women.  Subgrantees, organizations which receive Title X funding 
through one of the four grantees, include Planned Parenthood clinics, pediatric offices, hospitals, 
university health centers, youth organizations, and community health centers. 
 
Figure 2. Locations of Title X Subgrantees, 2007 
Made using Google Maps 
Stransky 2018 
The southeastern five counties are covered by AccessMatters, the northeastern counties 
are covered by Maternal Family Health Services, the central and southern counties are covered 
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by the Family Health Council of Central Pennsylvania, and western Pennsylvania is covered by 
Adagio Health.  Each dot is a clinic the organization lists as a recipient of Title X funding. 
4.1 ACCESSMATTERS 
AccessMatters serves Bucks, Chester, Delaware, Montgomery, and Philadelphia counties (see 
Figure 2); as of 2016 the combined population of these counties was just over four million in 
2016, and 806,348 of these residents were women and girls between the ages of 15 and 44 
(Pennsylvania Department of Health, 2018). Fifty-seven clinics, hospitals, and health centers 
receive Title X funds through AccessMatters: 41 in Philadelphia County, six in Delaware, four in 
Chester, four in Montgomery, and two in Bucks. 
 
Table 2. AccessMatters Insurance Status 
 
 
Unduplicated Number of Family Planning Users by Principal Health Insurance Coverage Status 
 
 
  
Principal Health Insurance Covering Primary Medical Care 
  
AccessMatters 
      N (%) 
 
Public health insurance covering primary medical care 42,841 (41.68) 
 
Private health insurance covering primary medical care  29,124 (28.34) 
 
Uninsured (no public or private health insurance) 26,414 (25.7) 
 
Unknown/not reported 4,392 (4.27) 
 Total Users 102,771 
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Forty-two percent of family planning patients at AccessMatters have public insurance 
such as Medicaid, and 26% are uninsured.  Twenty-eight percent have private insurance while 
4% of clients’ coverage is unknown. 
Table 3. AccessMatters Primary Method and Age Group 
Primary Method 
Under 
15  
15 to 
17  
18 to 
19  
20 to 
24  
25 to 
29  
30 to 
34  
35 to 
39  
40 to 
44  
Over 
44  
Total 
Female 
Users 
  
Female 
sterilization  
0 0 0 291 201 306 381 369 321 
1,869 
* IUD 11 194 418 1,516 1,685 1,103 688 319 147 6,081 
* Hormonal implant 41 440 508 1,013 756 398 170 53 19 3,398 
  
Rely on 
vasectomy 
0 0 0 3 2 10 9 10 6 
40 
  
Hormonal 
injection 
129 1,309 1,141 2,335 2,025 1,396 867 422 241 
9,865 
  Oral contraceptive 179 1,725 2,432 6,133 4,615 2,478 1,270 598 350 19,780 
  
Contraceptive 
patch 
15 90 122 308 268 122 52 18 8 
1,003 
  Vaginal ring 1 65 134 519 670 432 137 48 14 2,020 
  
Cervical cap or 
diaphragm 
7 64 65 73 63 38 19 22 16 
367 
  
Rely on male 
condom  
132 1,331 1,802 5,097 4,136 2,377 1,500 875 829 
18,079 
  
Contraceptive 
sponge 
0 0 0 0 0 0 1 0 0 
1 
  Female condom 0 8 5 18 17 15 15 5 10 93 
  Spermicide 25 132 79 146 128 83 60 44 33 730 
  FAM or LAM 3 4 10 48 40 55 26 22 19 227 
  
Withdrawal or 
other method 
1 52 76 231 216 149 106 67 398 
1,296 
  Abstinence 310 549 220 412 454 352 301 234 300 3,132 
  
Unknown/not 
reported 
306 1,523 1,159 1,586 1,629 1,172 875 598 785 
9,633 
No method 
          
  
Pregnant/seeking 
pregnancy 
20 180 358 1,337 1,698 1,215 687 249 71 
5,815 
  Other reason 66 243 355 1,109 1,014 682 530 382 450 4,831 
  
Total Female 
Users 1,246 7,909 8,884 22,175 19,617 12,383 7,694 4,335 4,017 88,260 
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Birth control methods are categorized into three levels of efficacy by the CDC: highly 
effective (female sterilization, IUD, implant, vasectomy), moderately effective (oral 
contraceptive, shot, patch, ring), and less effective (male condom, internal condom, sponge, 
fertility awareness method, and spermicide) and are color-coded above to reflect this.  Excluding 
patients who were seeking pregnancy, practicing abstinence, or were otherwise not using birth 
control, 14.36% used a highly effective method, 41.65% used a moderately effective method, 
and 25.75% used a less effective method.  Note that these reports combine women using fertility 
awareness method (FAM) and lactational amenorrhea method (LAM) despite different levels of 
efficacy; for the purposes of this report they are categorized as less effective and are used by less 
than half a percent of clients. 
 Of the 16,793 patients aged 15 to 19, 9.29% use either an implant or an IUD.  The most 
popular method for that age group is the pill, which is used by 24.75%.  Twenty to 24-year-olds 
at AccessMatters also most commonly used the pill (27.6%) with only 11.41% using a LARC 
method.   
4.2 ADAGIO HEALTH 
Adagio Health serves Allegheny, Armstrong, Beaver, Butler, Clarion, Clearfield, Crawford, Erie, 
Fayette, Greene, Indiana, Jefferson, Lawrence, McKean, Venango, Warren, Washington, and 
Westmoreland counties (see Figure 2).  As of 2016, the population of these counties was 3.2 
million, 574,161 of whom are women and girls aged 15 to 44.  Forty-seven organizations receive 
Title X funds through Adagio Health.  Twenty-two of these subgrantees are in Allegheny 
County, six in Westmoreland, three in Jefferson, two in Erie, two in Greene, two in Washington, 
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and one in Butler, Clarion, Clearfield, Crawford, Fayette, Indiana, Lawrence, McKean, and 
Venango, respectively.  No Title X subgrantees currently exist in Cameron, Elk, Forest, Mercer 
or Potter counties. 
 
Table 4. Adagio Health Insurance Status 
 Unduplicated Number of Family Planning Users by Principal Health Insurance Coverage Status 
    
Principal Health Insurance Covering Primary Medical Care 
  
Adagio Health 
      N (%) 
 
Public health insurance covering primary medical care 17,433 (41.54) 
 
Private health insurance covering primary medical care  14,610 (34.81) 
 
Uninsured (no public or private health insurance) 9,367 (22.32) 
 
Unknown/not reported 561 (1.34) 
 
Total Users  41,971 
 
Forty-two percent of Adagio family planning clients have public insurance, and 22% are 
uninsured.  Thirty-five percent of Adagio clients have private insurance. 
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Table 5. Adagio Health Primary Method and Age Group 
Primary Method 
Under 
15  
15 to 
17  
18 to 
19  
20 to 
24  
25 to 
29  
30 to 
34  
35 to 
39  
40 to 
44  
Over 
44   
Total 
Female 
Users  
  
Female 
sterilization  
0 0 0 10 86 262 325 366 768 
1,817 
* IUD  4 136 264 844 876 648 424 209 173 3,578 
* 
Hormonal 
implant 
35 248 278 578 417 200 102 46 17 
1,921 
  
Rely on 
vasectomy 
0 0 1 1 14 26 65 43 94 
244 
  
Hormonal 
injection 
107 834 782 1,257 1,077 801 644 328 336 
6,166 
  
Oral 
contraceptive 
131 1,014 1,264 3,065 2,196 1,203 607 282 274 
10,036 
  
Contraceptive 
patch 
7 28 20 54 29 13 7 4 2 
164 
  Vaginal ring 0 44 77 311 302 179 57 22 16 1,008 
  
Cervical cap or 
diaphragm 
0 0 0 1 4 3 6 0 2 
16 
  
Rely on male 
condom  
30 311 536 1,646 1,485 980 701 444 589 
6,722 
  
Contraceptive 
sponge 
0 0 0 0 0 0 0 1 0 
1 
  Female condom 0 1 1 1 1 0 0 1 0 5 
  Spermicide 0 1 0 0 0 2 3 0 1 7 
  FAM or LAM 0 0 7 20 25 26 26 14 25 143 
  
Withdrawal or 
other method 
3 8 18 67 54 55 45 42 88 
380 
  Abstinence 139 281 94 149 123 90 73 62 130 1,141 
  
Unknown/not 
reported 
19 89 76 227 186 153 127 111 338 
1,326 
No method                     
  
Pregnant/seeking 
pregnancy 
4 26 72 442 448 342 112 38 11 
1,495 
  Other reason 64 250 257 589 554 450 298 162 337 2,961 
  
Total Female 
Users 543 3,271 3,747 9,262 7,877 5,433 3,622 2,175 3,201 39,131 
  
Approximately 20.72%of sexually-active contraceptive users who received services 
funded by Adagio Health had a highly effective type of contraception, 47.65% had a moderately 
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effective type, and 19.89% used a less effective type.  Just over 13%  of 15 to 19-year olds used 
a LARC method, and the most popular method, at 32.46%, was the pill.  Among 20 to 24-year 
olds, 15.35% used a LARC method, while the most popular method was the pill, used by 
33.09%.  
4.3 MATERNAL AND FAMILY HEALTH SERVICES, INC. 
Maternal and Family Health Services, Inc. provides reproductive health care to residents of 16 
northeastern counties (see Figure 2).  As of 2016, 553,268 of the counties’ three million residents 
were women and girls aged 15 to 44-years old.  Five subgrantees are in Luzerne, four in 
Lackawanna, four in Susquehanna, two each in Berks, Lehigh, Pike, and Wyoming, and one each 
in Monroe, Northampton, Schuylkill, and Sullivan counties.  Although MFHS serves Bradford, 
Carbon, Tioga, and Wayne counties, there are currently no Title X recipients there. 
 
Table 6. MFHS Insurance Status 
 Unduplicated Number of Family Planning Users by Principal Health Insurance Coverage Status 
    
Principal Health Insurance Covering Primary Medical Care 
  
MFHS 
      N (%) 
 
Public health insurance covering primary medical care 13,580 (65.92) 
 
Private health insurance covering primary medical care  4,987 (24.21) 
 
Uninsured (no public or private health insurance) 2,034 (9.87) 
 
Unknown/not reported 0 
 
Total Users 20,601 
 
 30 
Among family planning clients at MFHS, 66% were covered by public insurance, 10% 
were uninsured, and 24% had private insurance.  
 
Table 7. MFHS Primary Method and Age Group 
Primary Method 
Under 
15 
15 to 
17  
18 to 
19  
20 to 
24  
25 to 
29  
30 to 
34  
35 to 
39  
40 
to 
44  
Over 
44   
Total 
Female 
Users  
  
Female 
sterilization  
0 0 0 3 21 34 53 20 50 
181 
* IUD 0 27 57 238 226 182 106 44 31 911 
* 
Hormonal 
implant 
10 98 127 246 182 100 34 14 7 
818 
  
Rely on 
vasectomy 
0 0 0 1 4 17 16 31 23 
92 
  
Hormonal 
injection 
28 328 363 667 503 295 198 148 91 
2,621 
  
Oral 
contraceptive 
54 621 1,028 2,226 1,258 729 370 178 107 
6,571 
  
Contraceptive 
patch 
2 4 11 27 22 10 9 5 0 
90 
  Vaginal ring 1 27 37 153 165 78 33 9 4 507 
  
Cervical cap or 
diaphragm 
0 1 0 2 4 4 0 0 0 
11 
  
Rely on male 
condom 
15 211 489 972 619 340 226 162 158 
3,192 
  
Contraceptive 
sponge 
0 1 0 0 0 0 1 0 0 
2 
  Female condom 0 1 1 3 1 1 0 1 0 8 
  Spermicide 0 0 0 1 0 1 0 0 1 3 
  FAM or LAM 0 0 1 1 6 12 3 2 6 31 
  
Withdrawal or 
other method 
0 2 5 12 15 10 9 8 6 
67 
  Abstinence 25 45 35 84 82 57 46 38 36 448 
  
Unknown/not 
reported 
1 18 61 158 121 73 39 19 14 
504 
No method                     
  
Pregnant/seeking 
pregnancy 
0 0 0 10 9 11 6 2 1 
39 
  Other reason 10 142 199 537 462 278 192 130 182 2,132 
  
Total Female 
Users 146 1,526 2,414 5,341 3,700 2,232 1,341 811 717 18,228 
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Among contraceptive users at MFHS, 11.28% used a highly effective method, 55.24% 
used a moderately effective method, and 18.62% used a less effective method.  Only 7.84% of 15 
to 19-year-old female patients used an IUD or implant, and the most popular method was again 
the pill at 41.85%.  Nine point zero seven percent of 20 to 24-year olds used a LARC method, 
and 41.68 percent opted for the pill. 
4.4 FAMILY HEALTH COUNCIL OF CENTRAL PENNSYLVANIA, INC. 
Twenty-four counties are served by FHCCPA; of the three million residents in these counties, 
553,727 are women and girls between 15 and 44-years old.  Thirty-one health centers and clinics 
receive Title X funding through FHCCPA: eight in Lancaster, six in York, three in Dauphin, two 
in Franklin, and one each in Adams, Bedford, Blair, Cambria, Centre, Cumberland, Lycoming, 
Mifflin, Northumberland, Snyder, Somerset, and Union counties.  No Title X funds are currently 
distributed in Clinton, Columbia, Fulton, Huntingdon, Juniata, Lebanon, Montour, or Perry 
counties.  
 
Table 8. FHCCPA Insurance Status 
 Unduplicated Number of Family Planning Users by Principal Health Insurance Coverage Status 
    
Principal Health Insurance Covering Primary Medical Care 
  
FHCCPA 
      N (%) 
 
Public health insurance covering primary medical care 17,379 (49.35) 
 
Private health insurance covering primary medical care  9,779 (27.77) 
 
Uninsured (no public or private health insurance) 8,061 (22.89) 
 
Unknown/not reported 0 
 
Total Users 35,219 
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Forty-nine percent of FHCCPA family planning patients had public insurance, 23% were 
uninsured, and 28% had private insurance. 
 
Table 9. FHCCPA Primary Method and Age Group 
Primary Method 
Under 
15  
15 to 
17 
18 to 
19  
20 to 
24 
25 to 
29  
30 to 
34  
35 to 
39  
40 to 
44  
Over 
44   
Total 
Female 
Users 
  
Female 
sterilization  
0 0 0 56 300 451 564 500 1,005 
2,876 
* IUD 2 31 96 437 502 349 218 103 50 1,788 
* 
Hormonal 
implant 
30 212 219 496 386 179 93 36 21 
1,672 
  
Rely on 
vasectomy 
1 10 18 53 52 50 37 26 54 
301 
  
Hormonal 
injection 
70 507 470 880 723 537 345 200 157 
3,889 
  
Oral 
contraceptive 
74 722 901 2,067 1,337 796 415 195 165 
6,672 
  
Contraceptive 
patch 
5 20 17 40 20 22 5 2 0 
131 
  Vaginal ring 0 26 33 135 136 81 25 5 2 443 
  
Cervical cap or 
diaphragm 
0 0 0 2 0 4 3 1 3 
13 
  
Rely on male 
condom  
29 280 412 886 648 393 263 149 222 
3,282 
  
Contraceptive 
sponge 
0 0 0 0 0 0 0 0 1 
1 
  Female condom 0 5 7 21 16 12 11 11 58 141 
  Spermicide 0 1 0 0 2 1 1 0 2 7 
  FAM or LAM 0 0 1 12 10 20 6 4 10 63 
  
Withdrawal or 
other method 
45 138 85 296 329 216 140 84 129 
1,462 
  Abstinence 164 248 85 136 116 88 101 71 311 1,320 
  
Unknown/not 
reported 
0 0 0 0 2 0 0 1 0 
3 
No method                     
  
Pregnant/seeking 
pregnancy 
6 44 121 519 488 259 130 47 17 
1,631 
  Other reason 41 199   749 740 562 391 271 769 3,722 
  
Total Female 
Users 467 2,443 2,465 6,785 5,807 4,020 2,748 1,706 2,976 29,417 
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About 25% of FHCCPA clients who used birth control chose a highly effective method 
while 42.12% used a moderately effective method, and 18.73% used a less effective method. 
Among 15 to 19-year-old patients, 11.37% used a LARC method while 33.07% of birth control 
users in that age group used the pill. LARCs were a slightly more popular choice among 20 to 
24-year olds at 13.75%, and the pill was again the most popular option at 30.46%. 
4.5 INSURANCE COVERAGE IN PENNSYLVANIA TITLE X CLINICS 
Previous research has shown that clinics which primarily serve publicly-insured individuals face 
financial barriers to providing LARCs (Vela et al., 2018).  The breakdown of insurance type 
among female family planning clients at Title X clinics differs from the insurance type among 
the general population of Pennsylvania.  In Pennsylvania, 36% of residents are insured through a 
public program while 59% have private insurance, and 5% are uninsured (KFF 2017).  In 
comparison, most Title X patients are publicly insured (Tables 2, 4, 6, 8), and about one quarter 
are uninsured.   
Pennsylvania currently restricts Medicaid coverage of outpatient LARC insertion and 
removal; if women receive multiple family planning services in one year, they are not eligible for 
LARC coverage.  Further, removal of a LARC is limited to once every three years.  Given the 
high proportion of publicly-insured clients at Title X clinics, providers may be hesitant to stock 
or recommend LARCs due to the above coverage restrictions.   
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Figure 3. Insurance Types, Pennsylvania General Population vs. Title X Grantees, Excluding "Coverage 
Unknown" 
Stransky 2018 
Per Figure 3, most patients receiving family planning care through Title X clinics are 
either uninsured or on public insurance.  Four percent of AccessMatters patients and 1% of 
Adagio clients were reported as “unknown/unreported.” 
4.6 LARC USE IN PENNSYLVANIA TITLE X CLINICS 
Oral contraceptives are the most popular method among all age groups for Title X clients using 
birth control, with 26.91% of women choosing them (see Figure 4).  The second most-used 
method is the male condom, at 19.55%, followed by the three-month hormonal injection, which 
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is used by 14.09% of clients.  IUDs are used by 7.72%, and the hormonal implant is used by 
4.88%. By effectiveness, 17.23% use a highly effective method, 44.61% use a moderately 
effective method, and 22.46% use a less effective method; 8.53% use no method and are not 
seeking pregnancy, and method is unknown for 7.17% (see Figure 4). 
 
 
Figure 4. Primary Method Among all Age Groups, Title X Female Contraceptive Users, 2017 
Stransky 2018 
 
Of the four Title X grantees, Adagio Health, which covers Western Pennsylvania, has the largest 
proportion of patients choosing a LARC method, 15.06%, followed by FHCCPA at 13.08%, 
AccessMatters at 11.95%, and MFHS at 9.74%.  Table 11 (below) shows the number and percent 
of women using LARCs by grantee. 
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Table 10.  Pennsylvania Title X female family planning patients not seeking pregnancy or practicing 
abstinence, by grantee 
 
Grantee 
# of 
Patients 
% of 
Patients 
AccessMatters 9,479 11.95% 
IUD 6,081 7.67% 
Implant 3,398 4.28% 
Adagio Health 5,499 15.06% 
IUD 3,578 9.80% 
Implant 1,921 5.26% 
MFHS 1,729 9.74% 
IUD 911 5.13% 
Implant 818 4.61% 
FHCCPA 3,460 13.08% 
IUD 1,788 6.76% 
Implant 1,672 6.32% 
Statewide 20,167 12.60% 
IUD 12,358 7.72% 
Implant 7,809 4.88% 
 
Women 20 to 24 years-old are at greatest risk of having an unintended pregnancy, 
followed by 15 to 19-year-olds.  As discussed in Chapter 2, these groups may have less access to 
LARCS based on physician perceptions about LARC suitability (e.g. parity or relationship 
status).  Data from the Pennsylvania Title X grantees reflect that, compared to other methods, 
IUD rates increase with age, reaching peak popularity among 30 to 34-year-olds (see Figure 5).  
Hormonal implants are most popular among adolescents who access family planning services, 
reaching a peak of 7.24% among girls 15 to 17-years old (Figure 5).  
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Figure 5. LARC Use Percentages by Age Group, Compared to Oral Contraceptives 
Stransky 2018 
It is important to note that the above data covers 164 clinics, and the counseling practices 
and variety of available methods between clinics likely vary greatly.    
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5.0  DISCUSSION 
The data presented above demonstrate that Pennsylvania women and girls aged 15 to 25 use 
LARCs at a lower rate than other methods and at a lower rate than other age groups.  In this 
section, the benefits of a statewide LARC intervention in Pennsylvania will be argued.   
5.1 PENNSYLVANIA IN COMPARISON TO OTHER STATES 
Among Pennsylvania Title X female family planning patients in 2017, 20,167 used a LARC 
method, with 12,358 women opting for an IUD and 7,809 opting for an implant.  LARC users 
comprised 11.52% of all patients and 12.6% of sexually active female patients not seeking 
pregnancy. 
In comparison, at the start of the Delaware CAN initiative in 2014, 13.7% of patients 
were using LARC methods; as of 2016 that had increased to 27% as a result of increased 
accessibility and affordability (Welti, 2018).  Similarly, at the start of the CFPI, 9.7% of 
Colorado Title X female family planning patients were using LARCs.  Within one year of the 
initiative, that increased to 14.7% and in 2015 had reached 30.5%.  By 2014, 31% of Colorado 
women aged 18 to 25 who used contraception were using LARCs (CDPHE, 2017).  During the 
Contraceptive CHOICE Project, when barriers of knowledge, cost, and access were removed, 
75% of women chose a LARC method.  Pennsylvania falls behind the national rate of LARC use 
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among Title X female family planning patients as well; per the 2017 FPAR, 16% of female 
patients were using either an IUD (9%) or an implant (7%) (Fowler, 2018).   
5.2 NEXT STEPS 
The data presented in Chapter 4 show contraceptive trends on multi-county and statewide levels.  
Clinic-level data can be constructed from the monthly reports submitted to the Title X grantees.   
While the insurance data presented above show that, overall, clinics are serving 
individuals with private and public insurance as well as those who are uninsured, a clinic-by-
clinic survey needs to be conducted to identify clinics that do not accept Medicaid and/or private 
insurance.  These data are already submitted by each subgrantee to the four Pennsylvania 
grantees for the annual Family Planning Assessment Report and obtaining it will not require any 
new data collection.  Once these clinics are identified, a survey will be conducted to determine 
the reasons any clinics do not bill public or private insurers.  Because these clinics primarily 
serve publicly-insured individuals, they may be facing greater financial barriers to LARC-
provision than clinics which primarily serve individuals with private insurance.   
Surveys will also need to be conducted among clinics not dispensing LARCs to 
determine the barriers.  A study of publicly-funded U.S. health providers that include family 
planning services found that 21% do not have any staff trained in providing LARCs (Bornstein, 
Carter, Zapata, Gavin, & Moskosky, 2018).  Of clinics that did not provide LARCs onsite, 65% 
had no formal referral process in place for patients seeking IUDs and 76% had no formal referral 
process for implants.  Training can be provided as needed in IUD and implant insertion and 
integrating LARCs into birth control counseling.  FPAR data can be used to create formal 
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referral networks for clinics which are unable to provide LARCs.  The cost of stocking LARCs 
has been cited as a barrier to providing them (Beeson et al., 2014).  In 2016, the Pennsylvania 
Department of Health implemented policies to increase financial support to LARC provision 
(Kostelac, 2016); however, there has been no research to examine if clinics have taken advantage 
of this financial support.  If costs are cited as a barrier, resources regarding state funding should 
be furnished to the clinics. 
Following the lead of the CFPI, training will also include birth control counseling to 
ensure women are able to select the method of contraception that works best for them.  Though 
the goal is to increase LARC use overall, it is essential to ensure that reproductive autonomy is 
respected above all else. Clinics will also be trained in doing single-visit LARC insertion so that 
women do not need to schedule multiple visits.  Part of this will be helping clinics stock LARC 
devices so they do not need to order them each time a client wants one.  
5.3 POTENTIAL IMPACT 
Using the FamilyScape microsimulation tool, Child Trends conducted simulations to estimate the 
impact greater LARC use nationally would have on unintended pregnancy rates, abortion rates, 
and negative childhood health outcomes.   The simulations used the 2006-2010 dataset from the 
National Survey for Family Growth, at which point 5.4% of sexually active women aged 15 to 
39 used LARCs.  If that was increased to 24.3%, the study predicted that the unintended 
pregnancy rate for that group would decrease by 64%, the unintended birth rate would drop by 
63% and the abortion rate would decrease by 67%.  Additionally, 23% fewer babies would be 
born with low birthweight and 24% fewer babies would be born prematurely.  The child health 
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outcomes were calculated purely based on preexisting proportions and do not account for other 
factors that could affect the amount of negative health outcomes in children such as pregnancy 
intention and access to prenatal care. 
Using 2010 data, a 64% decrease in Pennsylvania UIPs would mean 73,000 fewer UIPs.  
Similarly, using 2010 data and the above estimated decreases, there would be 26,968 fewer 
abortions and 37,674 fewer unintended births.  The public costs of UIPs in Pennsylvania totaled 
$727 million in 2010.  A 64% decrease in UIPs would translate to $465 million in public costs 
averted.  The decreases in the FamilyScape simulation exceed the rates reported in Colorado as a 
result of the CFPI, which saw a 40% decrease in UIPs among teens and a 20% decrease among 
20 to 24-year-olds.  Even a 20% drop in UIPs among all Pennsylvania women would avert $145 
million in public spending. 
5.4 COMMUNITY PARTNERS 
Upstream USA is currently partnered with Delaware to run the Delaware CAN program and is 
working to launch similar programs in Maryland and Washington. Upstream provides training on 
contraceptive counseling, LARC insertion and removal, billing and coding, and single-visit 
LARC provision.  Clinics in Pennsylvania would receive consistent, tried-and-true training were 
the state to partner with Upstream.   
While Upstream is the ideal partner for a LARC initiative, other options are available.  
The Colorado Family Planning Initiative partnered with hospitals and medical facilities 
throughout the state.  Taking advantage of the state’s winter tourism industry, high-end medical 
facilities that catered to skiers and snowboarders helped provide training.  If Pennsylvania did 
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not partner with an organization like Upstream, partnering with regional medical facilities may 
be another option.  Family planning organizations operating in Pennsylvania, such as Planned 
Parenthood, may be able to facilitate LARC training for other clinics; however, it may be 
necessary to have additional medical partners capable of providing this training due to issues like 
distance, availability, and potential discomfort with Planned Parenthood. Pennsylvania is home 
to several large hospital networks that can be recruited to aid in training Title X clinics in 
Medicaid and insurance billing as well as LARC insertion training.  The University of Pittsburgh 
Medical Center (UPMC) includes 35 hospitals and over 600 clinical locations across 
Pennsylvania.  Penn State Health, which includes Pennsylvania State University’s School of 
Medicine, has 78 clinical locations and is also a partner in the Pennsylvania Office of Rural 
Health (PORH). Because Pennsylvania has adopted a policy of increasing post-partum LARC 
insertion (Kostelac, 2016), hospitals with maternity wards located near Title X clinics may be 
able to provide training, if needed.   
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6.0  CONCLUSION 
Based on the data received from AccessMatters, Adagio Health, MFHS, and FHCCPA, it is 
evident that Pennsylvania is falling behind other states in providing a full range of birth control 
methods.  Recall from above that 12.6% of female contraceptive users at Pennsylvania Title X 
clinics use a LARC method, compared to 16% of Title X patients nationwide.  In addition, while 
Pennsylvania has the fifteenth lowest adolescent birth rate in the country, rural counties have 
seen far less positive change than their urban counterparts. 
 The CFPI, Contraceptive CHOICE Project, and Delaware CAN have all shown that, 
when clinics are provided with education, training, and resources to supply LARCs and financial 
barriers are removed, patients overwhelmingly choose those methods.  While the entire state of 
Pennsylvania experienced a reduction in teen pregnancies from 2007 to 2016, unintended 
pregnancies, and abortions, rural counties in particular had improved outcomes in these areas.    
By implementing a coordinated, statewide intervention, the CDPHE was able to increase the 
number of LARC providers, improve the financial viability and sustainability of clinics, and 
create a clinic-to-clinic referral system to ensure patient access. 
 While many states, including Colorado, Delaware, and California, have offices or 
divisions within their public health departments dedicated to family planning, Pennsylvania does 
not; however, the four organizations responsible for the receipt and distribution of Title X funds 
have the potential to form a coalition with each organization having familiarity and insight into 
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the respective clinics it oversees.  Because of this as well as the numerous sophisticated medical 
networks that can serve as community partners, Pennsylvania is well prepared to take the next 
steps to implementing a statewide initiative to increase the reproductive health options of its 
citizens.   
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APPENDIX: TITLE X SUBGRANTEES IN PENNSYVLANIA 
Below is a list of every health center that receives Title X funding from AccessMatters, Adagio 
Health, Maternal and Family Health Services, or Family Health Council of Central Pennsylvania.  
The list is grouped by which organization funds are received from and then listed alphabetically 
by county 
 
Adagio Health Services 
  County Clinic Name City, State, Zip 
 Allegheny Adagio Health Turtle Creek Turtle Creek, PA 15145 
 Allegheny 412 Youth Zone Pittsburgh, PA 15222 
 Allegheny Children Community Pediatrics Moon, PA 15018 
 Allegheny Children Community Pediatrics Pittsburgh, PA 15217 
 Allegheny Children Community Pediatrics White Oak, PA 15131 
 Allegheny UPMC Children's Hospital Pittsburgh, PA 15224 
 Allegheny UPMC Children's Hospital North Wexford, PA 15090 
 Allegheny UPMC Children's Hospital South Bridgeville, PA 15017 
 Allegheny Magee-Womens Hospital of UPMC Monroeville, PA 15146 
 Allegheny Magee-Womens Hospital of UPMC Mt.  Oliver Pittsburgh, PA 15210 
 Allegheny Magee-Womens Hospital of UPMC Wilkinsburg Wilkinsburg, PA 15221 
 Allegheny Magee-Womens Hospital of UPMC Outpatient Pittsburgh, PA 15213 
 Allegheny Planned Parenthood, Bridgeville Bridgeville, PA 15017 
 Allegheny Planned Parenthood, Moon Moon Township, PA 15108 
 Allegheny Planned Parenthood, Pittsburgh Pittsburgh, PA 15222 
 Allegheny South Hills Pediatric Associates Brentwood Brentwood, PA 15227 
 Allegheny Midwife Center Pittsburgh, PA 15222 
 Allegheny UPMC Matilda Theiss Health Center Pittsburgh, PA 15213 
 
Allegheny 
UPMC McKeesport Latterman Family Health 
Center McKeesport, PA 15132 
 Allegheny UPMC St.  Margaret Bloomfield-Garfield Pittsburgh, PA 15206 
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Allegheny UPMC St.  Margaret Lawrenceville Pittsburgh, PA 15201 
 Allegheny Adagio Health Aliquippa Aliquippa, PA 15001 
 Butler Adagio Health Butler Butler, PA 16001 
 Clarion Women's Healthcare of Clarion Clarion, PA 16241 
 Clearfield Penn Highlands Life's Journey OB/GYN DuBois, PA 15801 
 Crawford Meadville Community Health Center Meadville, PA 16335 
 Erie Adagio Health Edinboro Edinboro, PA 16412 
 Erie Adagio Health Erie Erie, PA 16501 
 Fayette Adagio Health Uniontown Uniontown, PA 15401 
 Greene Cornerstone Care Mt.  Morris Mt.  Morris, PA 15349 
 Greene Cornerstone Care Roversville Rogersville, PA 15359 
 Indiana Adagio Health Indiana Indiana, PA 15701 
 Jefferson Penn Highlands Life's Journey OB/GYN Punxsutawney, PA 15767 
 Jefferson Punxsutawney Physicians Services Punxsutawney, PA 15767 
 Jefferson Women's Healthcare of Clarion-Brookville Brookeville, PA 15825 
 Lawrence Adagio Health New Castle New Castle, PA 15101 
 McKean Bradford Regional Medical Center Bradford, PA 16701 
 Venango Adagio Health Seneca Seneca, PA 16346 
 Washington Cornerstone Care Burgettstown Burgettstown, PA 15021 
 Washington Cornerstone Care Washington Washington, PA 15301 
 Westmoreland Excela Health Medical Group Latrobe, PA 15650 
 Westmoreland Excela Health/Westmoreland Women's Health Scottdale, PA 15683 
 Westmoreland Excela Health OB/GYN Greensburg Greensburg, PA 15601 
 
Westmoreland Excela Health OB/GYN Greensburg Greensburg, PA 15601 
NOT A 
DUPLICATE 
Westmoreland Excela Health OBGYN North Huntington, PA 15642 
 Westmoreland Planned Parenthood, Greensburg Greensburg, PA 15601 
 
    AccessMatters 
   County Clinic Name City, State, Zip 
 Bucks Planned Parenthood, Bensalem Bensalem, PA 19020 
 Bucks Planned Parenthood, Quakertown Quakertown, PA 18951 
 Bucks Planned Parenthood, Warminster Warminster, PA 18974 
 Chester Chester County Youth Center West Chester, PA 19382 
 Chester PP Coatesville Coatesville, PA 19320 
 Chester La Comunidad Hispana Kennett Square, PA 19348 
 Chester Planned Parenthood, West Chester West Chester, PA 19382 
 Delaware Center for Family Health at Eastside Chester, PA 19013 
 Delaware Center for Family Health at Upper Darby Upper Darby, PA 19082 
 Delaware Crozer-Chester Medical Center Upland, PA 19013 
 Delaware Crozer-Chester at Lima Detention Center Lima, PA 19037 
 Delaware Planned Parenthood, Media Media, PA 19063 
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Delaware Planned Parenthood, of Upper Darby Upper Darby, PA 19082 
 Montgomery Lankenau Hospital Family Planning Service Wynnewood, PA 19096 
 Montgomery PHMC Carson Valley Flourtown, PA 19031 
 Montgomery Planned Parenthood, Norristown Norristown, PA 19401 
 Montgomery Planned Parenthood, Pottstown Pottstown 19464 
 Philadelphia African Family Health Organization Philadelphia, PA 19104 
 Philadelphia PDPH/Strawberry Mansion Health Center Philadelphia, PA 19132 
 Philadelphia Philadelphia Health and Education Corporation Philadelphia, PA 19102 
 Philadelphia Children's Hospital of Philadelphia, Karabots Philadelphia, PA 19139 
 Philadelphia Children's Hospital of Philadelphia, Cobbs Creek Philadelphia, PA 19139 
 Philadelphia CHOP Connection Covenant House Philadelphia, PA 19144 
 Philadelphia Congreso de Latinos Unidos Inc. Philadelphia, PA 19133 
 Philadelphia PHMC ACTS-II Woodstock Philadelphia, PA 19121 
 Philadelphia PHMC Care Clinic Philadelphia, PA 19123 
 Philadelphia PHMC Health Connections Philadelphia, PA 19122 
 Philadelphia PHMC Interim House West Philadelphia, PA 19104 
 Philadelphia PHMC Mary Howard Philadelphia, PA 19107 
 Philadelphia PHMC People's Emergency Center Philadelphia, PA 19104 
 Philadelphia PHMC Rising Sun Health Center Philadelphia, PA 19120 
 Philadelphia PHMC Stenton Manor  Philadelphia, PA 19138 
 Philadelphia Family Practice and Counseling Network Philadelphia, PA 19144 
 Philadelphia FPCN/Abbottsford Falls Philadelphia, PA 19144 
 Philadelphia Planned Parenthood, Castor Avenue Philadelphia, PA 19152 
 Philadelphia FPCN/11th Street Philadelphia, PA 19123 
 Philadelphia PP Elizabeth Blackwell Center Philadelphia, PA 19107 
 Philadelphia FPCN/Health Annex Philadelphia, PA 19142 
 Philadelphia Planned Parenthood, Locust Street Philadelphia, PA 19107 
 Philadelphia FPCN/Qcare Clinic Philadelphia, PA 19129 
 Philadelphia Kensington Hospital Medical Center Philadelphia, PA 19122 
 Philadelphia St.  Christopher's Hospital Philadelphia, PA 19134 
 Philadelphia Mazzoni Community Health Center Philadelphia, PA 19107 
 Philadelphia Spectrum Broad Street Health Center Philadelphia, PA 19122 
 Philadelphia Partnership Comprehensive Care Practice Philadelphia, PA 19102 
 Philadelphia Spectrum Health Center Philadelphia, PA 19139 
 Philadelphia Philadelphia Department of Public Health Philadelphia, PA 19145 
 Philadelphia Temple University Philadelphia, PA 19140 
 Philadelphia PDPH Philadelphia, PA 10104 
 Philadelphia Temple Student Health Philadelphia, PA 19122 
 Philadelphia PDPH Philadelphia, PA 19104 
 Philadelphia Thomas Jefferson University OBGYN Associates Philadelphia, PA 19107 
 Philadelphia PDPH Philadelphia, PA 19121 
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Philadelphia Urban Solutions Philadelphia, PA 19146 
 Philadelphia PDPH Philadelphia, PA 19123 
 Philadelphia Youth Health Empowerment Project Philadelphia, PA 19102 
 Philadelphia PDPH Philadelphia, PA 19144 
 Philadelphia PDPH Philadelphia, PA 19149 
 
    Maternal and Family Health Services, Inc. 
  County Clinic Name City, State, Zip 
 Berks Planned Parenthood, Reading Reading, PA 19602 
 
Berks 
Kutztown Universith Health Services (students 
only) Kutztown, PA 19530 
 Lackawanna MFHS Circle of Care Scranton, PA 18510 
 Lackawanna Keystone College Health Services LaPlume, PA 18840 
 Lackawanna Wright Center Student Health Services Scranton, PA 18504 
 Lackawanna Wright Center Mid Valley Jermyn, PA 18433 
 Lehigh Planned Parenthood, Allentown Allentown, PA 18104 
 Lehigh Vida Nueva at Casa Guadalupe Allentown, PA 18102 
 Luzerne Planned Parenthood, Wilkes-Barre Wilkes-Barre, PA 18701 
 Luzerne MFHS Hazleton Hazleton, PA 18201 
 Luzerne Valley Pediatrics Edwardsville, PA 18704 
 Luzerne Volunteers in Medicine Wilkes-Barre, PA 18702 
 Luzerne Keystone Job Corps Family Planning Center Drums, PA 18222 
 Monroe Pocono Medical Center East Stroudsburg, PA 18301 
 Northampton Bethlehem Health Bureau FP Clinic Bethlehem, PA 18018 
 Pike Pike County Family Health Center Hawley, PA 18428 
 Pike MFHS Circle of Care Hawley Hawley, PA 18428 
 Schuylkill MFHS Pottsville Center Pottsville, PA 17901 
 Sullivan Red Rock Job Corps Lopez, PA 18628 
 Susquehanna Family Health Clinic of  Barnes-Kasson Susquehanna, PA 18847 
 Susquehanna Family Health Center of Barnes-Kasson New Milford, PA 18847 
 Susquehanna NEPA Community Healthcare Susquehanna, PA 18847 
 Susquehanna NEPA Community Healthcare Hallstead, PA 18822 
 
Wyoming Monroe-Noxen Rural Health Center 
S.  Monroe Township, PA 
18636 
 Wyoming Exeter Township Rural Health Center Falls, PA 18615 
 
    Family Health Council of Central Pennsylvania, Inc. 
  County Clinic Name City, State, Zip 
 Adams Family First Health Gettysburg, PA 17325 
 Bedford UPMC Family Health Services Everett, PA 15537 
 Blair Women's Health and Wellness Center Altoona, PA 16601 
 Cambria Planned Parenthood, Johnstown Johnstown, PA 15901 
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Centre Mountain Top Area Medical Center Snow Shoe, PA 16874 
NOT A 
DUPLICATE 
Cumberland Dickinson College Student Health Services Carlisle, PA 17013 
 Dauphin Planned Parenthood, Keystone Harrisburg, PA 17102 
 Dauphin Hamilton Health Center Harrisburg, PA 17104 
 Dauphin Community Check-Up Center Harrisburg, PA 17104 
 
Franklin Keystone Health Chambersburg, PA 17201 
NOT A 
DUPLICATE 
Franklin Keystone Health Chambersburg, PA 17201 
NOT A 
DUPLICATE 
Lancaster Family First Health Columbia, PA 17512 
 
Lancaster Lancaster Health Center Lancaster, PA 17603 
NOT A 
DUPLICATE 
Lancaster Lancaster Health Center Lancaster, PA 17603 
 
Lancaster Lancaster Health Center Lancaster, PA 17603 
NOT A 
DUPLICATE 
Lancaster Lancaster General Health Lancaster, PA 17604 
 Lancaster Lancaster Health Center Lancaster, PA 17604 
 Lancaster Lancaster Health Center Lancaster, PA 17603 
 Lancaster Lancaster Health Center Lancaster, PA 17603 
 Lycoming River Valley Health & Dental Center Williamsport, PA 17701 
 Mifflin Family Planning Plus Lewistown, PA 17044 
 Northumberland Family Planning Plus Shamokin, PA 17872 
 Snyder Family Planning Plus Selinsgrove, PA 17870 
 Somerset Planned Parenthood, Somerset Somerset, PA 15501 
 Union Family Planning Plus Lewisburg, PA 17837 
 York Family First Health Lewisberry, PA 17339 
 York Family First Health Hanover, PA 17331 
 York Family First Health York, PA 17401 
 York Planned Parenthood, Keystone York, PA 17401 
 York Family First Health York, PA 17403 
 York York Community Health Center York, PA 17403 
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